Acute herpes zoster
Conditions
Interventions
Crisugabalin Besilate Capsules Group:NA
Sponsors
Hangzhou Third People's Hospital
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Able to understand and voluntarily sign a written informed consent form (ICF); 2.Age >= 50 years old; 3.Diagnosed with acute herpes zoster; 4.Presents with vesicles within 7 days; 5.Average pain visual analog scale (VAS) score >= 40 mm in the past 24 h assessed at screening.
Exclusion criteria
Exclusion criteria: 1.Participation in any other clinical study within 30 days prior to screening; 2.HZ vaccinated; 3.Received minimally invasive interventions with analgesic effects such as nerve block,nerve destruction, spinal cord stimulation, electrical stimulation, etc.; 4.Immunocompromised: mainly HIV/AIDS, malignant tumors, organ transplantation,stem cell transplantation patients,and long-term immunosuppressant treatment, etc.; 5.Ocular herpes zoster; 6.Other conditions that, in the judgement of the investigator, make participation in this study inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of PHN;NRS scores; | — |
Countries
China
Contacts
Public ContactJianming Yu
Hangzhou Third People's Hospital
Outcome results
None listed